《1320_Rao.pdf》由会员分享,可在线阅读,更多相关《1320_Rao.pdf(52页珍藏版)》请在三个皮匠报告上搜索。
1、See Important Safety Information referenced within.Information contained herein for DISPLAY in the U.S.ONLY.Not to be reproduced,distributed or excerpted.2025 Abbott.All rights reserved.MAT-2507761 v3.0Esprit BTK System:The Role of Drug-Eluting Resorbable Scaffolds for Infrapopliteal CLTISee Importa
2、nt Safety Information referenced within.Information contained herein for DISPLAY in the U.S.ONLY.Not to be reproduced,distributed or excerpted.2025 Abbott.All rights reserved.MAT-2507761 v3.0Device OverviewKarthik Gujja,MD,MPH,RPVIDirector for Endovascular Services,Mount Sinai South Nassau Medical C
3、enterESPRITBTK SYSTEMSee Important Safety Information referenced within.Information contained herein for DISPLAY in the U.S.ONLY.Not to be reproduced,distributed or excerpted.2025 Abbott.All rights reserved.MAT-2507761 v3.0Unmet Need for BTKBTK PAD1Small vessel diameterTortuous,challenging anatomyLo
4、nger lesion lengthSevere calcificationPOBASpecialty BalloonsAtherectomyIVLDESEsprit BTK DRSDRUG(Inhibit Neointimal Hyperplasia)SCAFFOLD(Resist Recoil)LEAVE NOTHING BEHIND*To effectively treat BTK PAD2Data on file at Abbott.*Excluding platinum markers1.Zeller T,et al.Orbital Atherectomy Prior to Drug
5、-Coated Balloon Angioplasty in Calcified Infrapopliteal Lesions:A Randomized,Multicenter Pilot Study.Journal od Endovascular Therapy.2022;29(6):874-884.2.Varcoe R,et al.Primary Outcomes of the Esprit BTK Drug-Eluting Resorbable Scaffold for the Treatment of Infrapopliteal Lesions:The LIFE-BTK Trial.
6、Presented at TCT 2023.Page 3 of 28See Important Safety Information referenced within.Information contained herein for DISPLAY in the U.S.ONLY.Not to be reproduced,distributed or excerpted.2025 Abbott.All rights reserved.MAT-2507761 v3.0PROCEDURAL STEPSPRODUCT LOGISTICSCASE REVIEWORDERING INFOPRODUCT